Get startedLog in
    Picture of Inmune Bio logo

    INMB — Inmune Bio News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Inmune Bio Inc. Announces Final Enrollment Of 208 Patients In Phase 2 Trial In Early Alzheimer's Disease

    Picture of Inmune Bio logoInmune Bio
    13/11/2024 14:02
    Nov 13 (Reuters) - INmune Bio Inc  INMB.O :
    * INMUNE BIO INC. ANNOUNCES FINAL ENROLLMENT OF 208 PATIENTS
IN
PHASE 2 TRIAL IN EARLY ALZHEIMER'S DISEASE

Source text:  ID:nGNX9dzqkN 
Further company coverage:  INMB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Inmune Bio

    See all news